Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Del Nido vs Buckberg in Aortic Valve Replacement
NCT04259515Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jul 2019
- Primary completion
- Aug 2023
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of del Nido cardioplegia in aortic valve disease (AVD), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: Mortality at 30 days, Troponin T at 5 days and 1 more. Started Jul 2019; status: completed.
02
Drugs
del Nido cardioplegia
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on NCT04259515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259515.